Apiam Animal Health Ltd (ASX: AHX) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Apiam Animal Health Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Apiam Animal Health Ltd (ASX: AHX)
Latest News
Share Market News
Apiam (ASX:AHX) share price soars 12% on strong Q1 update
Share Market News
ALL ORDINARIES finishes higher Thursday: 8 ASX shares you missed
Cheap Shares
Are Telstra shares and these 2 ASX stocks too cheap to ignore?
Share Market News
Greencross share price rises after receiving court approval for the takeover
⏸️ Diversification
Buy these 3 ASX shares to instantly diversify your portfolio
Cheap Shares
Are cheap value ASX shares about to create the best returns?
Share Market News
Here's why all insane valuations will eventually become sane one way or another
Growth Shares
Why I'm excited by these 2 ASX small caps
Share Market News
5 things to watch on the ASX on Wednesday
⏸️ Diversification
Buy these 3 stocks to instantly diversify your portfolio
Best Shares
Why one top fund manager thinks these two "clobbered" vet stocks will rebound
Share Market News
Who else wants to diversify their portfolio?
Dividend Payment History Data provided by Morningstar.
Ex-Date | Amount | Franking | Type | Payable |
---|---|---|---|---|
28 Aug 2024 | $0.0100 | 100.00% | Final | 30 Sep 2024 |
04 Mar 2024 | $0.0100 | 100.00% | Interim | 03 Apr 2024 |
21 Sep 2022 | $0.0040 | 100.00% | Final | 21 Oct 2022 |
21 Mar 2022 | $0.0120 | 100.00% | Interim | 20 Apr 2022 |
16 Sep 2021 | $0.0120 | 100.00% | Final | 22 Oct 2021 |
19 Mar 2021 | $0.0120 | 100.00% | Interim | 23 Apr 2021 |
17 Sep 2020 | $0.0120 | 100.00% | Final | 23 Oct 2020 |
20 Mar 2020 | $0.0080 | 100.00% | Interim | 24 Apr 2020 |
19 Sep 2019 | $0.0080 | 100.00% | Final | 24 Oct 2019 |
19 Mar 2019 | $0.0080 | 100.00% | Interim | 24 Apr 2019 |
19 Sep 2018 | $0.0080 | 100.00% | Final | 26 Oct 2018 |
13 Mar 2018 | $0.0080 | 100.00% | Interim | 27 Apr 2018 |
20 Sep 2017 | $0.0000 | 100.00% | Final | 27 Oct 2017 |
13 Mar 2017 | $0.0080 | 100.00% | Interim | 27 Apr 2017 |
AHX ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
---|---|---|---|---|---|
YesNo |
About Apiam Animal Health Ltd
Apiam Animal Health Ltd provides products and services to support the health and welfare of production and mixed animals. The company offers veterinary wholesale, warehousing, logistics, and other ancillary services. Its operating segmentsinclude Dairy and Mixed, Feedlots and Pigs. It generates the majority of its revenue from Dairy and Mixed. The Group operates in the segment of provision of veterinary products and services to production, companion and equine animals.
AHX Share Price History Data provided by Morningstar.
Date | Close | Change | % Change | Volume | Open | High | Low |
---|---|---|---|---|---|---|---|
10 Dec 2024 | $0.40 | $0.00 | 0.00% | 85,398 | $0.38 | $0.40 | $0.38 |
09 Dec 2024 | $0.40 | $0.01 | 2.56% | 118,810 | $0.39 | $0.40 | $0.39 |
06 Dec 2024 | $0.39 | $0.01 | 2.63% | 135,268 | $0.38 | $0.40 | $0.38 |
05 Dec 2024 | $0.38 | $-0.01 | -2.60% | 172,461 | $0.39 | $0.39 | $0.38 |
04 Dec 2024 | $0.39 | $0.00 | 0.00% | 22,970 | $0.39 | $0.40 | $0.39 |
03 Dec 2024 | $0.39 | $0.01 | 2.63% | 7,695 | $0.39 | $0.39 | $0.38 |
02 Dec 2024 | $0.38 | $-0.01 | -2.56% | 40,952 | $0.40 | $0.41 | $0.38 |
29 Nov 2024 | $0.39 | $0.00 | 0.00% | 6,413 | $0.40 | $0.40 | $0.39 |
28 Nov 2024 | $0.39 | $0.02 | 5.33% | 19,220 | $0.38 | $0.40 | $0.38 |
27 Nov 2024 | $0.38 | $0.02 | 5.56% | 89,662 | $0.37 | $0.38 | $0.37 |
26 Nov 2024 | $0.36 | $-0.01 | -2.74% | 181,233 | $0.37 | $0.38 | $0.36 |
25 Nov 2024 | $0.37 | $-0.03 | -7.59% | 530,923 | $0.40 | $0.44 | $0.35 |
22 Nov 2024 | $0.40 | $-0.03 | -7.14% | 146,454 | $0.42 | $0.42 | $0.40 |
21 Nov 2024 | $0.42 | $-0.04 | -8.70% | 642,567 | $0.45 | $0.45 | $0.35 |
20 Nov 2024 | $0.46 | $-0.01 | -2.13% | 49,360 | $0.47 | $0.47 | $0.46 |
19 Nov 2024 | $0.47 | $0.01 | 2.17% | 15,408 | $0.47 | $0.47 | $0.46 |
18 Nov 2024 | $0.46 | $0.00 | 0.00% | 33,373 | $0.46 | $0.48 | $0.46 |
15 Nov 2024 | $0.46 | $-0.04 | -8.00% | 194,262 | $0.50 | $0.50 | $0.46 |
14 Nov 2024 | $0.50 | $0.00 | 0.00% | 45,376 | $0.50 | $0.50 | $0.49 |
13 Nov 2024 | $0.50 | $-0.01 | -1.98% | 15,508 | $0.50 | $0.51 | $0.50 |
12 Nov 2024 | $0.51 | $0.00 | 0.00% | 30,617 | $0.51 | $0.51 | $0.51 |
Director Transactions Data provided by Morningstar.
Date | Director | Type | Amount | Value | Notes |
---|---|---|---|---|---|
29 Nov 2024 | Christopher Richards | Issued | 478,905 | $186,772 |
Issue of securities. 763,533 Performance Right
|
31 Oct 2024 | Christopher Richards | Expiry | 192,821 | $102,195 |
As advised by the company. 284,628 Performance Rights, lapsed
|
30 Sep 2024 | Christopher Richards | Buy | 873,864 | $423,998 |
Dividend Reinvestment Plan (DRP).
|
30 Sep 2024 | Jan Tennent | Buy | 2,591 | $1,257 |
Dividend Reinvestment Plan (DRP).
|
30 Sep 2024 | Andrew Vizard | Buy | 7,134 | $3,461 |
Dividend Reinvestment Plan (DRP).
|
30 Sep 2024 | Richard (Rick) Dennis | Buy | 256 | $124 |
Dividend Reinvestment Plan (DRP).
|
31 May 2024 | Christopher Richards | Buy | 311,715 | $106,668 |
Off-market trade. As per announcement on 04-06-2024
|
30 May 2024 | Christopher Richards | Buy | 38,209 | $13,885 |
On-market trade.
|
03 Apr 2024 | Andrew Vizard | Buy | 10,075 | $3,361 |
Dividend Reinvestment Plan (DRP).
|
03 Apr 2024 | Christopher Richards | Buy | 1,174,271 | $391,736 |
Dividend Reinvestment Plan (DRP).
|
03 Apr 2024 | Richard (Rick) Dennis | Buy | 361 | $120 |
Dividend Reinvestment Plan (DRP).
|
03 Apr 2024 | Jan Tennent | Buy | 3,659 | $1,220 |
Dividend Reinvestment Plan (DRP).
|
28 Mar 2024 | Christopher Richards | Buy | 1,701,996 | $595,698 |
On-market trade.
|
Directors & Management Data provided by Morningstar.
Name | Title | Start Date | Profile |
---|---|---|---|
Professor Andrew Lancelot Vizard | Non-Executive ChairmanNon-Executive Director | Nov 2015 |
Professor Vizard is a Principal Fellow at the Faculty of Veterinary and Agricultural Sciences, University of Melbourne and previously Associate Professor of Veterinary Epidemiology and Director of The Mackinnon Project, a recognized leader in sheep and beef veterinary consultancy. An experienced company director, he has previously held directorships in ASX companies, statutory bodies and research organizations including Animal Health Australia, the body responsible for coordinating Australia's animal health system; Primesafe, the statutory authority responsible for regulating the production of safe meat in Victoria. He is currently Chair of the Vizard Foundation and Executive Secretary for the Hermon Slade Foundation and the Australia & Pacific Science Foundation.
|
Mr Bruce Robert Dixon | Non-Executive Director | Oct 2024 |
Mr Dixon has over 30 years of management, commercial and Board experience including as Nonexecutive Director of Greencross Limited (one of Australias largest veterinary and pet care providers) and Ruralco Limited (Australian agribusiness). Mr Dixon was also the founder and Chair of Australian Venue Co, where following its sale to KKR in 2017, he remained on the AVC Board and as a shareholder until its sale earlier this year to PAG Asia Capital. Mr Dixon also previously held the position of Chief Executive Officer of Spotless Group Holdings Ltd and Healthscope Limited. Mr Dixon is currently Executive Director of Linen Services Australia (formally Spotless Linen) as well as a Director of a number of private companies.
|
Mr Richard (Rick) John Dennis | Non-Executive Director | Nov 2015 |
Mr Dennis held several senior roles for over 35 years with Ernst & Young (EY) and was the Managing Partner of EYs Queensland practice on two occasions from 2001-2007 and from 2014-15. Rick also held several executive management roles at EY, including Deputy COO and CFO for the Asia-Pacific practice where he was responsible for overseeing the financial and operational integration of EYs Australian and Asian member firms. Rick is a member of Australian Super's Queensland Advisory Board, a member of the Advisory Boards of EWM Group and HLB Chessboard, and an external member of the Audit & Risk Committee of Racing Queensland.
|
Ms Evonne Maree Collier | Non-Executive Director | Oct 2022 |
Ms Collier is an experienced leader combining current board (ASX, private, publicly unlisted) and governance experience with a successful career in Executive Director level Marketing, Innovation/Technology and Commercial roles managing large profit or loss and balance sheets across diverse industries in blue-chip, multi-national organizations. She has a track record in bringing high growth strategic direction to organizations including commercializing transformative, new to world products and services and an expert background in driving brand profile, customer experience/journeying and growing market share and sales across channels, including digital products/services.
|
Dr Christopher Irwin Richards | Managing Director | Mar 2015 |
Dr Richards is the Managing Director of Australian subsidiary entities and joint venture companies, which provide veterinary services to Australian regional and rural communities. Chris is responsible for the strategic direction of Apiam, which has seen the develop, grow, acquire and integrate production and companion animal veterinary clinics, veterinary wholesale, logistics, laboratory and genetics services businesses since 1998 into the Apiam of today Chris is also a director of registered charity, Fur Life Foundation Ltd, which raises funds to support people in rural, regional, and remote communities
|
Ms Eryl Baron | Company Secretary | Nov 2020 |
-
|
Matthew White | Chief Financial Officer |
-
|
|
Renee Waters | Chief People Officer |
-
|
|
Duncan Runciman | Chief Veterinary Officer |
-
|
|
Eryl Baron | Company Secretary |
-
|
Top Shareholders Data provided by Morningstar.
Name | Shares | Capital |
---|---|---|
Cjoea Family Company Pty Ltd <Richards Family A/C> | 36,661,071 | 20.21% |
Petstock Investments Pty Ltd | 21,240,500 | 11.71% |
UBS Nominees Pty Ltd | 10,947,749 | 6.03% |
Citicorp Nominees Pty Limited | 8,228,248 | 4.53% |
BNP Paribas Nominees Pty Ltd <Ib Au Noms Retailclient> | 3,363,296 | 1.85% |
3Fj Pty Ltd <Fojo Super Fund A/C> | 3,138,174 | 1.73% |
Mr Brian Scutt | 2,728,822 | 1.50% |
HSBC Custody Nominees (Australia) Limited | 2,682,139 | 1.48% |
Cjoea Family Company Pty Ltd <Richards Family A/C> i | 2,655,767 | 1.46% |
J P Morgan Nominees Australia Pty Limited | 1,977,759 | 1.09% |
Cobash Pty Limited <J & S Wright Family A/C> | 1,872,006 | 1.03% |
Mr Roger Charles Carmody & Mrs Maris Moore Carmody <Sandridge S/F A/C> | 1,742,791 | 0.96% |
Jinland Pty Ltd <Jinland Family A/C> | 1,740,000 | 0.96% |
Orem Holdings Pty Ltd | 1,669,306 | 0.92% |
Hamilton Animal Health Pty Ltd | 1,564,270 | 0.86% |
Certane Ct Pty Ltd <Apiam Animal Est Unallo Ac> | 1,484,009 | 0.82% |
Fergus Macbeth Hay | 1,446,946 | 0.80% |
Four Post Investments Pty Ltd <Johnstone Investment A/C> | 1,386,700 | 0.76% |
Mrs Rachel Louise O'Meara | 1,377,888 | 0.76% |
Michael James Whiteford | 1,347,657 | 0.74% |
Sarah Leonnie Jalim | 1,347,657 | 0.76% |
Simon James Robinson | 1,347,657 | 0.74% |